ZA745252B - New halogen pyrozoles derivatives, a method for producing these halogen pyrazole derivatives and medicaments containing them - Google Patents

New halogen pyrozoles derivatives, a method for producing these halogen pyrazole derivatives and medicaments containing them

Info

Publication number
ZA745252B
ZA745252B ZA00745252A ZA745252A ZA745252B ZA 745252 B ZA745252 B ZA 745252B ZA 00745252 A ZA00745252 A ZA 00745252A ZA 745252 A ZA745252 A ZA 745252A ZA 745252 B ZA745252 B ZA 745252B
Authority
ZA
South Africa
Prior art keywords
halogen
derivatives
pyrozoles
producing
medicaments containing
Prior art date
Application number
ZA00745252A
Inventor
R Riedel
G Rainer
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of ZA745252B publication Critical patent/ZA745252B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA00745252A 1973-08-16 1974-08-15 New halogen pyrozoles derivatives, a method for producing these halogen pyrazole derivatives and medicaments containing them ZA745252B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU68238A LU68238A1 (en) 1973-08-16 1973-08-16

Publications (1)

Publication Number Publication Date
ZA745252B true ZA745252B (en) 1976-03-31

Family

ID=19727442

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00745252A ZA745252B (en) 1973-08-16 1974-08-15 New halogen pyrozoles derivatives, a method for producing these halogen pyrazole derivatives and medicaments containing them

Country Status (18)

Country Link
JP (1) JPS5230515B2 (en)
AT (1) AT339892B (en)
BE (1) BE818912A (en)
CA (1) CA1048499A (en)
CH (1) CH601250A5 (en)
DE (2) DE2462459C3 (en)
DK (1) DK136953B (en)
ES (1) ES429247A1 (en)
FI (1) FI57584C (en)
FR (1) FR2240732B1 (en)
GB (1) GB1475806A (en)
IE (1) IE39999B1 (en)
LU (1) LU68238A1 (en)
NL (1) NL169070C (en)
NO (1) NO140733C (en)
SE (1) SE409454B (en)
YU (1) YU222474A (en)
ZA (1) ZA745252B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5297383A (en) * 1976-02-13 1977-08-16 Ngk Spark Plug Co Ceramic honeycomb structures for exhaust gas purification
HUP0304101A3 (en) * 2003-12-22 2008-10-28 Sanofi Aventis Pyrazole derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates

Also Published As

Publication number Publication date
NO742941L (en) 1975-03-17
DE2438779A1 (en) 1975-02-27
CH601250A5 (en) 1978-06-30
DK136953C (en) 1978-05-29
YU222474A (en) 1983-04-27
GB1475806A (en) 1977-06-10
DK136953B (en) 1977-12-19
SE409454B (en) 1979-08-20
FR2240732A1 (en) 1975-03-14
FR2240732B1 (en) 1978-07-21
IE39999L (en) 1975-02-16
DE2462459A1 (en) 1977-04-07
NL7410921A (en) 1975-02-18
DK438174A (en) 1975-04-28
FI57584C (en) 1980-09-10
LU68238A1 (en) 1975-05-21
DE2438779B2 (en) 1979-01-25
BE818912A (en) 1975-02-17
ATA671174A (en) 1977-03-15
JPS5049278A (en) 1975-05-01
AT339892B (en) 1977-11-10
FI242274A (en) 1975-02-17
ES429247A1 (en) 1976-08-16
NL169070C (en) 1982-06-01
NL169070B (en) 1982-01-04
NO140733C (en) 1979-10-31
DE2462459C3 (en) 1979-10-04
DE2462459B2 (en) 1979-02-08
JPS5230515B2 (en) 1977-08-09
SE7410419L (en) 1975-02-17
CA1048499A (en) 1979-02-13
NO140733B (en) 1979-07-23
FI57584B (en) 1980-05-30
IE39999B1 (en) 1979-02-14
DE2438779C3 (en) 1979-09-20

Similar Documents

Publication Publication Date Title
IL40971A0 (en) Substituted pyrimidone-(4) derivatives,a method for producing them and medicaments containing them
HU172697B (en) Process for producing thieno-bracket-2,3-c-bracket closed-pyridine derivatives
HU173540B (en) Process for preparing new 5-oxa-prostaglandin derivatives
HU171401B (en) Process for producing 2-alkoxyalkyl-1,4-dihydropyridine derivatives
YU309481A (en) Process for preparing new dibenzoxepine derivatives
HK7977A (en) Pyrazole derivatives, process for their preparation and their use as medicaments
IL45823A0 (en) Basically substituted 1,4-dihydro-2h-isoquinoline derivatives and process for preparing them
HU172465B (en) Process for producing new thia-prostaglandine derivatives
HU173985B (en) Process for preparing d-8alpha,8beta-disubstituted-6-methyl-ergoline and -ergolene derivatives
ZA746435B (en) Triglycidyl compounds, a process for their manufacture and their use
BG24226A3 (en) Method of preparing derivatives of 2-aminomethyl-4,6-dihalidephenol
YU102382A (en) Process for preparing new benzodiazepine derivatives
HU175423B (en) Process for preparing new pyrazole derivatives
ZA745252B (en) New halogen pyrozoles derivatives, a method for producing these halogen pyrazole derivatives and medicaments containing them
HU173395B (en) Process for producing estrene-3,17-dion derivatives
AU506082B2 (en) 2-benzopyranone derivatives, a process for their production and their use as medicaments
HU172101B (en) Process for preparing new 2,3-dioxo-piperazine derivatives
HU171165B (en) Process for producing oktahydro-indolo-bracket-2,3-a-bracket closed-quinolizine derivatives
HU172063B (en) Process for producing antiallergene n-bracket-5-tetrazolyl-bracket-closed-1-oxo-6-alkoxy-1h-pyrimido-bracket-1,2-a-bracket closed-quinolime-2-carboxamide derivatives
HU172055B (en) Process for producing thieno-bracket-3,2-c-bracket closed-pyridine derivatives
HU174067B (en) Process for producing substituted 2h-pyrane-2,6-dion derivatives
HU171824B (en) Process for producing new 2,3-methylene-prostaglandine derivatives
HU172343B (en) Process for producing 1,2,4-triazole derivatives
HU173039B (en) Process for producing 9-alkoxy- or -allyloxy-5-alkyl- or -alkenyl-6,7-benzomorphane derivatives
ZA746632B (en) Basically substiduted 1,4-dihydro-2h-isoquinoline derivatives and process for preparing them